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Introduction 
In the summer of 2004, then-U.S. Senate candidate from Illinois Barack
Obama galvanized the nation with a message centered on the hope,
promise, and power of the American dream. He said Americans possess
the “audacity of hope,”1 which, as much as any phrase of recent origin,
describes the impetus behind both the conduct and support of medical
research. This is not mere rhetoric. More than the citizens of any other
nation, Americans support medical research.2-3 Over the course of 13
years, Research!America polling has consistently found that two-thirds
of Americans support significant increases in federal investment in
research (Figure 1).
Americans have always expected scientific progress, and to an astonishing
degree these high expectations have been met. The Americans whom
Tom Brokaw termed the “Greatest Generation”4 have seen extraordinary
advances in science, particularly in medical science. Thanks to research,
we have added years—and quality—to life. We have witnessed the
discovery of penicillin, antibiotics, insulin, and the polio vaccine; the
identification of the AIDS virus; the sequencing of the human genome;
the establishment of the link between tobacco and cancer; the develop-
ment of effective interventions to control high blood pressure and high
cholesterol; and much more. A century ago, the average U.S. citizen 
lived to be 48 years old. Now we live to an average age of 77 because 
of advances in public health and medical health care, all made possible
through research.5
Thanks to investment in medical and health research, at least 241,000
stroke deaths, 815,000 coronary heart disease deaths, and 62,000 deaths
from HIV/AIDS are prevented annually in the United States.6 Today,
there are approximately 35 million Americans ages 65 and older who,
because of improvements in health care and nutrition, are more likely
than ever to be healthy, vigorous, and productive.
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The Challenges Ahead
On March 17, 2004, in testimony before the House
Appropriations Subcommittee on Labor, Health and
Human Services, Education and Related Agencies, the
director of the National Institute on Aging, Richard J.
Hodes, M.D., noted that disability among America’s
seniors has declined steadily over the past decade. He
stated that “more older Americans are able to partici-
pate in the instrumental activities of daily living, such as
performing household chores and managing their own
medications, while fewer are experiencing limitations in
basic physical tasks such as walking or climbing stairs.”7
However, Dr. Hodes also reported that the diseases
of aging still affect many Americans and seriously
compromise the quality of their lives. “More than 
half of all Americans over age 65 show evidence of
osteoarthritis in at least one joint,” he said. “More
than half of Americans over age 50 have osteoporosis
or low bone mass … and as many as 4.5 million
Americans suffer from Alzheimer’s disease.”7
Moreover, 4,200 Americans still die every day of 
five major diseases: heart disease, cancer, stroke,
diabetes, and Alzheimer’s.8 This translates to more
than 1.55 million deaths every year—more than all
the American combat deaths from the American
Revolution to the Iraq war combined.
Audacity of hope allows Americans to imagine that
many more deaths could be prevented through curing
diabetes and Parkinson’s, eliminating Alzheimer’s,
halting macular degeneration, and identifying more
effective treatments for depression and other mental
illnesses. We can also imagine eliminating the pain 
and suffering of cancer—a goal that National Cancer
Institute Director Andrew C. von Eschenbach, M.D.,
believes will be achieved by 2015.9 Achieving these and
similarly audacious goals is indeed possible, but only if
the commitment made by the Greatest Generation to
invest in medical research continues.
Economic Benefits of Medical Research
There are compelling economic as well as health
reasons to continue our investment in research. For
example, medical costs for overweight and obesity
total more than $90 billion per year in the United
States, and about 9 percent of aggregate medical
spending goes to treating obesity-related diseases.
Each taxpayer is responsible for $180 per year on
obesity-related medical costs for public sector health
plans.10 Audacity of hope allows Americans to imag-
ine halting the obesity epidemic in its tracks and
ensuring our dollars are used instead to achieve
improved and more affordable health care.
Carolyn Clancy, M.D., director of the Federal
Agency for Healthcare Research and Quality, has
said that “we pay for and receive excellent care one-
third of the time, unnecessary care one-third of the
time, and one-third of the time our care is character-
ized by mistakes, errors, or underuse of clinically
appropriate treatments.”11 In response, AHRQ is
working to improve health care through health serv-
ices research, which examines how people get access
to health care, how much care costs, and what hap-
pens to patients as a result of this care.
Increased investment in health services research is
needed to address national policy challenges, such as
how to translate research into evidence-based prac-
tice, how to reinvent a system of patient care based
on valuing quality, and how to moderate the crushing
financial and health implications of an aging society.
The rising cost of health care in the United States,
already nearing unsustainable levels, will escalate fur-
ther as baby boomers reach retirement age and enter
the Medicare system. According to the Task Force on
Aging Research Funding, in 25 years the number of
Americans ages 65 and older will double to more
than 70 million. The number of people ages 85 and
Investing in Medical Research:
Why We Must Embrace the “Audacity of Hope”
By Mary Woolley
 
older will increase fourfold. As a result, the U.S.
health care system will experience a costly burden.
Currently, health care spending increases by almost
10 percent a year. If research has not reduced further
the incidence of age-related diseases by that time, the
cost will be devastating.12
Stagnation in Federal Support for  Medical Research
For decades, Americans and their elected and
appointed officials looked at equations about the cost
benefit of research and said, in effect, “What are we
waiting for?” The words of celebrated advocate for
medical research Mary Lasker (1901–1994) carried
the day: “If you think research is expensive, try dis-
ease!” Just a few years ago, U.S. Congress and both
the Bill Clinton and George W. Bush administrations
acted to double the National Institutes of Health
(NIH) budget over a five-year period. During those
years, other federal agencies’ budgets—including those
of the CDC and the National Science Foundation—
were similarly expanded, and private-sector research
was encouraged through regulation and tax incentives
to step up their research investment as well. Public
support was behind these expansions every step of the way.
Today, many of the same officials who formerly lis-
tened to their constituencies, as well as to their own
common sense, are balking at the cost of keeping
pace with scientific opportunity through adequate
investment in research. Not only is research spending
stagnating, it is also being impeded by ideologically
driven concerns. Legislators are being pushed by
interest groups to intervene in the peer-review
process and deny funding to reproductive and sexual
health research, as well as to research utilizing embry-
onic stem cells, which could one day lead to cures for
Parkinson’s, Alzheimer’s, and diabetes.
Elected officials cite lack of available dollars as a reason
to stall investment in research. Funding the war on
terror and the war in Iraq as well as sustaining tax cuts
have contributed to exploding the national deficit,
leaving few dollars for so-called discretionary spend-
ing, including medical and health research. But unless
we find new dollars, new discoveries will have to wait.
Research!America public opinion polling shows that
Americans have high expectations for new cures, treat-
ments, and preventions—so much so that 67 percent
are willing to pay a dollar more per week in taxes.13
Medical Research as Fuel for Economic Growth
Meanwhile, as research investment stalls, U.S. global
leadership in research is being threatened. In the
August 2, 2004, issue of The New Yorker, business
journalist John Cassidy argued that “the keys to
economic success are a well-educated workforce,
technical know-how, high levels of capital investment,
and entrepreneurial zeal—all of which countries can
acquire with the help of supportive governments.”14
Many countries, including Japan, China, and Britain,
have made decisions that they expect will allow 
them to match or surpass U.S. leadership in medical
research while simultaneously fueling their own
economic growth. Cassidy stated that for the United
States to be successful in our global economy, it will
have to ensure that “its scientists are the most creative,
its business leaders the most innovative, and its work-
ers the most highly skilled—not easy when other
nations are seeking the same goals.”
What can we do to meet these challenges? We must
act as a nation to continue supporting what NIH
Director Elias Zerhouni, M.D., terms “quantum
leaps.”15 “We have witnessed nothing short of a revolu-
tion in science over the past five years,” Dr. Zerhouni
said. “Some may see this  [NIH budget doubling] as
the grand finale. I think of it more as the overture. As
the twenty-first century begins to unfold, we are
poised to make quantum leaps in our knowledge about
how to improve people’s health.” Such advances will
require increased investment, but they will be much
less costly in the long run than paying for disease and
disability in an aging population. Without strong
investment in research, exciting opportunities will be
lost or long delayed, and brilliant young researchers
will be attracted to other countries that are increasingly
Figure 1
Strong support for doubling scientific research budget
There is a proposal to double our total national spending on
government-sponsored science and engineering research over
five years. In general, do you favor or oppose this idea?
SOURCE: “TAKING OUR PULSE: THE PARADE/RESEARCH!AMERICA HEALTH POLL” CONDUCTED BY
CHARLTON RESEARCH COMPANY, 2004
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more competitive with U.S. science and are striving to
match our world leadership status. Most importantly,
more lives will be needlessly lost.
When the quantum leaps in medical research that permit
prevention of cancer through personalized genomic
fingerprinting take place first in China or Japan, or when
Britain is the first to understand—and interrupt—the
epidemic of obesity, Americans of all generations will ask,
“Why did we put off investing more in medical and
health research when the opportunity was within our
grasp?” They will ask questions both personal and socie-
tal, questions with unsettling consequences. For example:
“Why do I have to take my husband to another country
for the noninvasive surgery that will cure his Parkinson’s
or Alzheimer’s?” “Why has the United States replicated
its loss of dominance in the automobile industry by losing
its dominance in pharmaceuticals and biotechnology?”
“Where did all the good jobs in those industries go?”
Conclusion
The Greatest Generation’s leadership can and must be
reprised in this new century by a new generation’s audac-
ity of hope. The twenty-first century must be a time
when what was once only imagined can be realized. If we
make it clear to our nation’s leaders that we must invest
our dollars as well as our hopes in medical and health
research, all of us—our children and grandchildren—will
realize a healthier, more productive future.
Mary Woolley has served since 1990 as president and CEO
of Research!America, the nation’s largest not-for-profit
alliance for medical and health research advocacy, with 500
organizational members representing well over 100 million
Americans. The author is grateful to Research!America col-
leagues Sharon Berry and Turna Ray for their significant
contributions to this paper.
Afterword
By Robert N. Butler, M.D.
One of the remarkable events of the twentieth century
was the deferral of disease, disability, and death to the
later years of life and the dramatic reduction of morbidity
and mortality of women, infants, and children. In this
issue brief, Mary Woolley makes clear the great contribu-
tion of biomedical research to the remarkable triumph of
survivorship and its tremendous cost-effectiveness. There
is no question that biomedical research contains health
costs and expands productive capabilities of older persons,
as well as reduces disability rates and improves quality of
Vaccination has resulted in the eradication of smallpox,
elimination of poliomyelitis in the Americas, and control
of other infectious diseases.
Motor-vehicle safety has improved dramatically with
advances in engineering and increased public awareness
to make road travel safer and to save lives.
Safer workplaces have resulted in a reduction of approxi-
mately 40 percent in the rate of fatal occupational
injuries.
Control of infectious diseases has resulted from assur-
ance of clean water and improved sanitation.
Decline in deaths from coronary heart disease and
stroke has resulted from smoking cessation and blood-
pressure control, coupled with improved access to early
detection and better treatment.
Safer and healthier foods have resulted from decreases 
in microbial contamination and increases in nutritional
content.
Healthier mothers and babies have resulted from better
hygiene and nutrition, availability of antibiotics, greater
access to health care and technological advances in
maternal and neonatal medicine. Since 1900, infant mor-
tality has decreased 90 percent and maternal mortality
has decreased 99 percent.
Family planning has increased opportunities for precon-
ception counseling and screening; fewer infant, child, and
maternal deaths; and the use of barrier contraceptives to
prevent pregnancy, HIV, and other STDs.
Fluoridation of drinking water safely and inexpensively
prevents tooth decay, regardless of socioeconomic status
or access to care.
Recognition of tobacco use as a health hazard and
subsequent public health anti-smoking campaigns have
resulted in changes in social norms to prevent tobacco
use, promote cessation of use, and reduce exposure to
environmental tobacco smoke.
From the “Ten Great Public Health Achievements—United States,
1900–1999,” 1999, Morbidity and Mortality Weekly Report
48(12):241–3, U.S. Centers for Disease Control and Prevention.
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life. This becomes all the more important with the
deferral of full eligibility for Social Security from 65 to
67 by the year 2027.
I have observed an unfortunate tendency to blame older
people for health costs, without consideration that it is
the very deferral of disease, disability, and death result-
ing from medical advances that enables people to reach
old age. After all, none of us would wish to return to
the “good old days” when women regularly died in
childbirth, when life-threatening diseases like smallpox,
polio, and scarlet fever claimed thousands of American
lives annually, and antibiotics were unknown.
When calculating health costs one must consider
inflation, the high cost of new diagnostic and treat-
ment technologies, the great costs associated with
treating a variety of conditions that exist earlier in life,
such as in neonatology units, accidents and trauma in
emergency rooms, as well as tragically early onsets of
the major killers—heart disease, cancer, and stroke.
This issue brief comes at an especially important time.
It is the summer season for advocacy on behalf of the
National Institutes of Health (NIH), the major bio-
medical research institution of the world. Its budget is
stagnant, compromising the likelihood of further
progress in the conquest of disease.
The total NIH budget is barely $30 billion, which, in
the larger scheme of our economy—some $11 tril-
lion—is a modest investment indeed. And biomedical
research is an investment. All of us are affected one
way or another by disease. All of us should join the
army of advocates on behalf of Research!America, so
ably led by Mary Woolley.
Robert N. Butler, M.D., president and CEO of the
International Longevity Center-USA, is co-chair of the
Alliance for Health & the Future and professor of geriatrics
at Mount Sinai School of Medicine.
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how greater life expectancy and increased
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